首页 | 本学科首页   官方微博 | 高级检索  
     


Glioblastoma in the Canton of Zurich,Switzerland revisited: 2005 to 2009
Authors:Dorothee Gramatzki MD  Silvia Dehler MD  Elisabeth Jane Rushing MD  Kathrin Zaugg MD  PhD  Silvia Hofer MD  Yasuhiro Yonekawa MD  Helmut Bertalanffy MD  Anton Valavanis MD  Dimitri Korol MD  Sabine Rohrmann PhD  Miklos Pless MD  Joachim Oberle MD  Patrick Roth MD  Hiroko Ohgaki PhD  Michael Weller MD
Affiliation:1. Department of Neurology, University Hospital Zurich, Zurich, Switzerland;2. Zurich and Zug Cancer Registry, University Hospital Zurich, Zurich, Switzerland;3. Department of Neuropathology, University Hospital Zurich, Zurich, Switzerland;4. Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland;5. Department of Oncology, University Hospital Zurich, Zurich, Switzerland;6. Department of Neurosurgery, University Hospital Zurich, Zurich, Switzerland;7. Department of Neuroradiology, University Hospital Zurich, Zurich, Switzerland;8. Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland;9. Department of Oncology, Kantonsspital Winterthur, Winterthur, Switzerland;10. Department of Neurosurgery, Kantonsspital Winterthur, Winterthur, Switzerland;11. International Agency for Research on Cancer, Lyon, France
Abstract:
Keywords:epidemiological study  glioblastoma  isocitrate dehydrogenase 1 (IDH1)  O6 methylguanine DNA methyltransferase (MGMT)  survival  temozolomide
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号